PUBLIC | NASDAQ:DNLI Focus on neurodegenerative diseases such as Parkinson’s and Alzheimer’s http://www.denalitherapeutics.com/ Press Releases Denali Therapeutics Receives Orphan Drug and Rare Pediatric Disease Designation for DNL310, and Expands its Portfolio of...
